Abstract |
3-([4-(4-Chlorophenyl)piperazin-1-yl]-methyl)-1H-pyrrolo-2, 3-beta-pyridine (L-745,870) is a dopamine D(4) selective antagonist that has been studied as a potential treatment for schizophrenia, with the expectation that it would not exhibit the extrapyramidal side effects often observed with the use of classical antipsychotic agents. The metabolism of L-745,870 in vivo was investigated in the rat, rhesus monkey, and human using liquid chromatography-tandem mass spectrometry and/or NMR techniques in conjunction with radiochemical detection. In all three species, two major metabolic pathways were identified, namely N-dealkylation at the substituted piperazine moiety and the formation of a novel mercapturic acid adduct. It is proposed that the latter biotransformation process involves the formation of an electrophilic imine methide intermediate, analogous to that produced from 3-methyl indole. This report appears to represent the first example of metabolic activation of a 3-alkyl-7-azaindole nucleus.
|
Authors | K E Zhang, P H Kari, M R Davis, G Doss, T A Baillie, K P Vyas |
Journal | Drug metabolism and disposition: the biological fate of chemicals
(Drug Metab Dispos)
Vol. 28
Issue 6
Pg. 633-42
(Jun 2000)
ISSN: 0090-9556 [Print] United States |
PMID | 10820134
(Publication Type: Journal Article)
|
Chemical References |
- 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine
- DRD4 protein, human
- Dopamine Antagonists
- Dopamine D2 Receptor Antagonists
- Drd4 protein, rat
- Pyridines
- Pyrroles
- Receptors, Dopamine D2
- Receptors, Dopamine D4
- Acetylcysteine
|
Topics |
- Acetylcysteine
(metabolism, urine)
- Animals
- Dopamine Antagonists
(metabolism, pharmacology, urine)
- Dopamine D2 Receptor Antagonists
- Humans
- Macaca mulatta
- Male
- Pyridines
(metabolism, pharmacology, urine)
- Pyrroles
(metabolism, pharmacology, urine)
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine D2
(metabolism)
- Receptors, Dopamine D4
|